Excellence is just the beginning.

Translate

French German Italian Portuguese Russian

Cutaneous T-Cell Lymphoma Clinic — Clinical Trials

Cutaneous T-Cell Lymphoma Treatment Study

A phase 3 multicenter, randomized, placebo-controlled study to determine the effect of topical SGX301 and fluorescent bulb-light irradiation for the treatment of cutaneous T-cell lymphoma.

Treatment Study for Patients with Anaplastic Large Cell Lymphoma

A randomized phase 2 trial of brentuximab vedotin (SGN35, NSC# 749710), or crizotinib (NSC#749005, commercially labeled) in combination with chemotherapy for newly diagnosed patients with anaplastic large cell lymphoma (ALCL) IND#117117.

Treatment Study for Patients with Cutaneous T-Cell Lymphoma

A clinical study to demonstrate safety and efficacy of E7777 (denileukin diftitox) in persistent or recurrent cutaneous T-cell lymphoma.

Treatment Study for the Mycosis Fungoides Form of Cutaneous T-Cell Lymphoma

A double blind, randomized, vehicle controlled, crossover study to evaluate the safety and efficacy of a topical lotion, for the relief of pruritus in patients with the mycosis fungoides (MF) form of cutaneous T-cell lymphoma (CTCL).